CONTE, BENEDETTA
CONTE, BENEDETTA
Dipartimento di Medicina Traslazionale
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies
2024-01-01 Conte, B; Brasó-Maristany, F; Hernández, Ar; Pascual, T; Villacampa, G; Schettini, F; Losada, Mjv; Seguí, E; Angelats, L; Garcia-Fructuoso, I; Gómez-Bravo, R; Lorman-Carbó, N; Paré, L; Marín-Aguilera, M; Martínez-Sáez, O; Adamo, B; Sanfeliu, E; Fratini, B; Falato, C; Chic, N; Vivancos, A; Villagrasa, P; Staaf, J; Parker, Js; Perou, Cm; Prat, A
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
2020-01-01 Prat, A; Guarneri, V; Paré, L; Griguolo, G; Pascual, T; Dieci, Mv; Chic, N; BRASÓ-MARISTANY, F; Vidal, M; Conte, B; Oliveira, M; Saura, C; Pernas, S; Alarcón, J; LLOMBART-CUSSAC, A; Cortés, J; Manso, L; López, R; Ciruelos, E; Schettini, F; Villagrasa, P; Carey, La; Perou, Cm; Piacentini, F; D'Amico, R; Tagliafico, E; Parker, Js; Conte, P
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate
2022-01-01 Poggio, F; Tagliamento, M; Ceppi, M; Bruzzone, M; Conte, B; Fregatti, P; Punie, K; DE AZAMBUJA, E; DEL MASTRO, L; Lambertini, M
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial
2023-01-01 Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L
Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management
2025-01-01 Nardin, Simone; Ruffilli, Beatrice; Landolfo, Tommaso Lupo; Isingrini, Giulia; Taglialatela, Ida; Delbarba, Andrea; D'Avanzo, Francesca; Rossi, Valentina; Celentano, Eduardo; Conte, Benedetta; Nardin, Matteo; Gennari, Alessandra
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers
2021-01-01 Fregatti, P; Gipponi, M; Giacchino, M; Sparavigna, M; Diaz, R; Fioravanti, E; Cornacchia, C; Conte, B; Lambertini, M; Zoppoli, G; Murelli, F; Toni, Ml; Calabro, Mt; Orsino, L; Friedman, D
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
2021-01-01 MARTÍNEZ-SÁEZ, O; Pascual, T; BRASÓ-MARISTANY, F; Chic, N; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Schettini, F; Conte, B; Vidal, M; Adamo, B; Martínez, A; Muñoz, M; Moreno, R; Villagrasa, P; Salvador, F; Ciruelos, Em; Faull, I; Odegaard, Ji; Prat, A
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
2021-01-01 Schettini, F; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Pascual, T; Conte, B; MARTÍNEZ-SÁEZ, O; Adamo, B; Vidal, M; Barnadas, E; FERNÁNDEZ-MARTÍNEZ, A; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Cejalvo, Jm; Perrone, G; Sabarese, G; Zalfa, F; Peg, V; Fasani, R; Villagrasa, P; Gavilá, J; Barrios, Ch; Lluch, A; Martín, M; Locci, M; DE PLACIDO, S; Prat, A
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
2025-01-01 Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sánchez-Bayona, Rodrigo; Pascual, Tomás; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence
2022-01-01 Conte, B.; Soldato, D.; Razeti, M. G.; Fregatti, P.; de Azambuja, E.; Schettini, F.; Prat, A.; Del Mastro, L.; Lambertini, M.
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
2022-01-01 Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
2020-01-01 Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; D’ Alonzo, Alessia; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
2020-01-01 Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Ceppi, Marcello; Del Mastro, Lucia
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial
2020-01-01 Conte, B.; Bruzzone, M.; Lambertini, M.; Poggio, F.; Bighin, C.; Blondeaux, E.; De Laurentiis, M.; Valle, E.; Cognetti, F.; Nistico, C.; De Placido, S.; Garrone, O.; Gamucci, T.; Montemurro, F.; Puglisi, F.; Cardinali, B.; Fregatti, P.; Miglietta, L.; Boccardo, F.; Ceppi, M.; Del Mastro, L.
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial
2024-01-01 Poggio, F.; Blondeaux, E.; Tagliamento, M.; Perachino, M.; Nardin, S.; Conte, B.; Giuliano, M.; Arpino, G.; De Laurentiis, M.; Gravina, A.; Bisagni, G.; Rimanti, A.; Turletti, A.; Nisticò, C.; Magnolfi, E.; Gasparro, S.; Fabi, A.; Garrone, O.; Alicicco, M. G.; Urracci, Y.; Poletti, P.; Correale, P.; Molinelli, C.; Fozza, A.; Puglisi, F.; Colantuoni, G.; Fregatti, P.; Boni, L.; Lambertini, M.; Del Mastro, L.
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial
2025-01-01 Seguí, E; Brasó-Maristany, F; Pascual, T; Sanfeliu, E; Victoria, I; Saura, C; Hierro, C; López-González, A; Izarzugaza, Y; Ciruelos, E; Gavilá, J; Racca, F; Cejalvo, J M; Amillano, K; Paz-Ares, L; Juan, M; Felip, E; Garralda, E; González, B; Arance, A; Martín-Liberal, J; Conte, B; Walbaum, B; Indacochea, A; Castillo, O; Blasco, P; Pardo, F; Aguirre, Á; Sirenko, V; González, X; Galván, P; Vivancos, A; Ferrero-Cafiero, J M; Mulero-Sánchez, A; Salvador, F; Villacampa, G; Mesía, R; Cervantes, A; Prat, A; Tabernero, J
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
2021-01-01 Schettini, F; Giuliano, M; Giudici, F; Conte, B; DE PLACIDO, P; Venturini, S; Rognoni, C; DI LEO, A; Locci, M; Jerusalem, G; DEL MASTRO, L; Puglisi, F; Conte, P; DE LAURENTIIS, M; Pusztai, L; Rimawi, Mf; Schiff, R; Arpino, G; DE PLACIDO, S; Prat, A; Generali, D
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
2020-01-01 MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients
2017-01-01 Conte, B; DEL MASTRO, L
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients
2017-01-01 Conte, Benedetta; Del Mastro, Lucia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies | 1-gen-2024 | Conte, B; Brasó-Maristany, F; Hernández, Ar; Pascual, T; Villacampa, G; Schettini, F; Losada, Mjv; Seguí, E; Angelats, L; Garcia-Fructuoso, I; Gómez-Bravo, R; Lorman-Carbó, N; Paré, L; Marín-Aguilera, M; Martínez-Sáez, O; Adamo, B; Sanfeliu, E; Fratini, B; Falato, C; Chic, N; Vivancos, A; Villagrasa, P; Staaf, J; Parker, Js; Perou, Cm; Prat, A | |
| A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation | 1-gen-2020 | Prat, A; Guarneri, V; Paré, L; Griguolo, G; Pascual, T; Dieci, Mv; Chic, N; BRASÓ-MARISTANY, F; Vidal, M; Conte, B; Oliveira, M; Saura, C; Pernas, S; Alarcón, J; LLOMBART-CUSSAC, A; Cortés, J; Manso, L; López, R; Ciruelos, E; Schettini, F; Villagrasa, P; Carey, La; Perou, Cm; Piacentini, F; D'Amico, R; Tagliafico, E; Parker, Js; Conte, P | |
| Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate | 1-gen-2022 | Poggio, F; Tagliamento, M; Ceppi, M; Bruzzone, M; Conte, B; Fregatti, P; Punie, K; DE AZAMBUJA, E; DEL MASTRO, L; Lambertini, M | |
| Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial | 1-gen-2023 | Conte, B; Montemurro, F; Levaggi, A; Blondeaux, E; Molinelli, C; Cardinali, B; Poggio, F; Buzzatti, G; Bighin, C; Lambertini, M; DEL MASTRO, L | |
| Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management | 1-gen-2025 | Nardin, Simone; Ruffilli, Beatrice; Landolfo, Tommaso Lupo; Isingrini, Giulia; Taglialatela, Ida; Delbarba, Andrea; D'Avanzo, Francesca; Rossi, Valentina; Celentano, Eduardo; Conte, Benedetta; Nardin, Matteo; Gennari, Alessandra | |
| Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers | 1-gen-2021 | Fregatti, P; Gipponi, M; Giacchino, M; Sparavigna, M; Diaz, R; Fioravanti, E; Cornacchia, C; Conte, B; Lambertini, M; Zoppoli, G; Murelli, F; Toni, Ml; Calabro, Mt; Orsino, L; Friedman, D | |
| Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy | 1-gen-2021 | MARTÍNEZ-SÁEZ, O; Pascual, T; BRASÓ-MARISTANY, F; Chic, N; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Schettini, F; Conte, B; Vidal, M; Adamo, B; Martínez, A; Muñoz, M; Moreno, R; Villagrasa, P; Salvador, F; Ciruelos, Em; Faull, I; Odegaard, Ji; Prat, A | |
| Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer | 1-gen-2021 | Schettini, F; Chic, N; BRASÓ-MARISTANY, F; Paré, L; Pascual, T; Conte, B; MARTÍNEZ-SÁEZ, O; Adamo, B; Vidal, M; Barnadas, E; FERNÁNDEZ-MARTÍNEZ, A; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Cejalvo, Jm; Perrone, G; Sabarese, G; Zalfa, F; Peg, V; Fasani, R; Villagrasa, P; Gavilá, J; Barrios, Ch; Lluch, A; Martín, M; Locci, M; DE PLACIDO, S; Prat, A | |
| Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis | 1-gen-2025 | Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sánchez-Bayona, Rodrigo; Pascual, Tomás; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele | |
| De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence | 1-gen-2022 | Conte, B.; Soldato, D.; Razeti, M. G.; Fregatti, P.; de Azambuja, E.; Schettini, F.; Prat, A.; Del Mastro, L.; Lambertini, M. | |
| Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | 1-gen-2022 | Prat, A; Guarneri, V; Pascual, T; BRASÓ-MARISTANY, F; Sanfeliu, E; Paré, L; Schettini, F; Martínez, D; Jares, P; Griguolo, G; Dieci, Mv; Cortés, J; LLOMBART-CUSSAC, A; Conte, B; MARÍN-AGUILERA, M; Chic, N; PUIG-BUTILLÉ, Ja; Martínez, A; Galván, P; Tsai, Yh; GONZÁLEZ-FARRÉ, B; Mira, A; Vivancos, A; Villagrasa, P; Parker, Js; Conte, P; Perou, Cm | |
| Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study | 1-gen-2020 | Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; D’ Alonzo, Alessia; Poggio, Francesca; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; Del Mastro, Lucia | |
| Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial | 1-gen-2020 | Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Ceppi, Marcello; Del Mastro, Lucia | |
| Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial | 1-gen-2020 | Conte, B.; Bruzzone, M.; Lambertini, M.; Poggio, F.; Bighin, C.; Blondeaux, E.; De Laurentiis, M.; Valle, E.; Cognetti, F.; Nistico, C.; De Placido, S.; Garrone, O.; Gamucci, T.; Montemurro, F.; Puglisi, F.; Cardinali, B.; Fregatti, P.; Miglietta, L.; Boccardo, F.; Ceppi, M.; Del Mastro, L. | |
| Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial | 1-gen-2024 | Poggio, F.; Blondeaux, E.; Tagliamento, M.; Perachino, M.; Nardin, S.; Conte, B.; Giuliano, M.; Arpino, G.; De Laurentiis, M.; Gravina, A.; Bisagni, G.; Rimanti, A.; Turletti, A.; Nisticò, C.; Magnolfi, E.; Gasparro, S.; Fabi, A.; Garrone, O.; Alicicco, M. G.; Urracci, Y.; Poletti, P.; Correale, P.; Molinelli, C.; Fozza, A.; Puglisi, F.; Colantuoni, G.; Fregatti, P.; Boni, L.; Lambertini, M.; Del Mastro, L. | |
| Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial | 1-gen-2025 | Seguí, E; Brasó-Maristany, F; Pascual, T; Sanfeliu, E; Victoria, I; Saura, C; Hierro, C; López-González, A; Izarzugaza, Y; Ciruelos, E; Gavilá, J; Racca, F; Cejalvo, J M; Amillano, K; Paz-Ares, L; Juan, M; Felip, E; Garralda, E; González, B; Arance, A; Martín-Liberal, J; Conte, B; Walbaum, B; Indacochea, A; Castillo, O; Blasco, P; Pardo, F; Aguirre, Á; Sirenko, V; González, X; Galván, P; Vivancos, A; Ferrero-Cafiero, J M; Mulero-Sánchez, A; Salvador, F; Villacampa, G; Mesía, R; Cervantes, A; Prat, A; Tabernero, J | |
| Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis | 1-gen-2021 | Schettini, F; Giuliano, M; Giudici, F; Conte, B; DE PLACIDO, P; Venturini, S; Rognoni, C; DI LEO, A; Locci, M; Jerusalem, G; DEL MASTRO, L; Puglisi, F; Conte, P; DE LAURENTIIS, M; Pusztai, L; Rimawi, Mf; Schiff, R; Arpino, G; DE PLACIDO, S; Prat, A; Generali, D | |
| Frequency and spectrum of PIK3CA somatic mutations in breast cancer | 1-gen-2020 | MARTÍNEZ-SÁEZ, O; Chic, N; Pascual, T; Adamo, B; Vidal, M; GONZÁLEZ-FARRÉ, B; Sanfeliu, E; Schettini, F; Conte, B; BRASÓ-MARISTANY, F; Rodríguez, A; Martínez, D; Galván, P; Rodríguez, Ab; Martinez, A; Muñoz, M; Prat, A | |
| Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients | 1-gen-2017 | Conte, B; DEL MASTRO, L | |
| Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients | 1-gen-2017 | Conte, Benedetta; Del Mastro, Lucia |